Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.
Attovia Therapeutics is a biologics platform specializing in biotherapeutics for immune-mediated diseases.
Replimune Group develop the next generation of ‘oncolytic immunotherapies’ for the treatment of cancer.
We provide simple, sophisticated respiratory solutions for post-ICU and home environments, eliminating unnecessary cost and complexity.
Gritstone bio is a biotechnology company that develops immunotherapies for cancer and infectious diseases.
Attralus is a biopharmaceutical company focusing on creating transformative medicines to improve the lives of patients.
EmployerDirect Healthcare is a supplemental healthcare benefit that directs planned medical procedures to high-quality providers.
IGM Biosciences is a biotechnology company that develops medicine for people with infectious infections, autoimmune diseases, and cancer.
Zentalis is a pharmaceutical company focused on developing clinical therapeutics for cancer patients.
Krystal Biotech provide significant clinical benefit for patients suffering from rare debilitating disorders..
OncoResponse is an immuno-oncology biotech company developing cancer immunotherapies leveraging human immune system responses.
Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.
MedAvail focuses on the discovery, development, and commercialization of advanced nutrition products.
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Escient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs.
Achilles Therapeutics is a developer of immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.
Home Biosciences is a European venture builder dedicated to biotech.
Sphere Bio specializes in tools for single cell analysis and isolation, facilitating discovery in the biotech field.
Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.
Zentera Therapeutics is a biopharmaceutical company.
Mnemo Therapeutics specializes in biotechnology and life science.
Ayala Pharmaceuticals a clinical-stage biopharmaceutical company focused on developing and commercializing small molecule therapeutics.
Lava Therapeutics is a developer of a bispecific antibody platform used to engage gamma-delta T cells for the treatment of cancer.
Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases.
Redmile Group has invested in 104 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Redmile Group's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 16 different industry categories.
Among tracked funding rounds, Pliant Therapeutics received $287.5M in a Post Ipo Equity round. Redmile Group's total known invested capital is $12.1B.
Redmile Group's average investment size is $128.9M across its portfolio of 104 companies.
Recent Redmile Group portfolio additions include Atara Biotherapeutics, Attovia Therapeutics, Replimune Group, CorVent Medical, Gritstone bio. These companies were founded in 2020 or later.